Navigation Links
ADVENTRX Pharmaceuticals to Present at the 10th Annual BIOInvestor Forum Conference on October 26
Date:10/19/2011

SAN DIEGO, Oct. 19, 2011 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the 10th Annual BIOInvestor Forum Conference on Wednesday, October 26, 2011 at 1:30 p.m. Pacific time, in the Sea Cliff Salon at the Palace Hotel in San Francisco.

Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals web site at www.adventrx.com. An archived presentation will be available on the web site for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company focused on developing proprietary product candidates.  The Company's current lead product candidates are ANX-188, a novel, purified, rheologic and antithrombotic compound initially being developed as a first-in-class treatment for pediatric patients with sickle cell disease in acute crisis, and ANX-514, a detergent-free formulation of the blockbuster drug Taxotere®, which recently went off-patent.  The Company is seeking a partner or outside investor for its Exelbine program.  More information can be found on the Company's web site at www.adventrx.com.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
10. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 24, 2017 A coalition ... International Development (USAID), the W.K. Kellogg Foundation and ... the Saint Boniface Haiti Foundation (SBHF) last week ... Port-au-Prince . The partnership provides ... Pou Amelyore Ekipman Medikal (REPARE) program, enabling the ...
(Date:1/24/2017)... , Jan. 24, 2017 Italy Ultrasound Systems Market ... ... Market Outlook to 2022", provides key market data on the ... of US dollars, volume (in units) and average prices (USD) ... Real-Time 3D/4D Ultrasound Systems and Hand Held Ultrasound (HHU) Systems. ...
(Date:1/24/2017)... 24, 2017 Asia-Pacific Bone Densitometers Market ... report, "Asia-Pacific Bone Densitometers Market Outlook to 2022", ... Densitometers market. The report provides value, in millions ... prices (USD) within market segements - Dual Energy ... The report also provides company shares and distribution ...
Breaking Medicine Technology:
(Date:1/24/2017)... , ... January 24, 2017 , ... A fifth-year speaker ... of Cypress Benefit Administrators, will return to present about the state of the Affordable ... a “Benefits Adventure” theme this year – will be hosted at Disney’s Grand Californian ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... the expansion of its Medication Counseling Centers to address market needs. To support ... MCC staff by more than 60 percent over the past 6 months. The ...
(Date:1/24/2017)... New York, New York (PRWEB) , ... January 24, 2017 , ... ... demand for Brazilian butt lifts is on the rise. According to the American ... buttock augmentations since 2000. On average, these procedures are performed every 30 minutes of ...
(Date:1/24/2017)... Bethesda, MD (PRWEB) , ... January 24, 2017 ... ... Medical Informatics Association (AMIA) commended the Patient-Centered Outcomes Research Institute (PCORI) for developing ... informaticians suggested that PCORI consider requiring a preliminary data sharing plan as part ...
(Date:1/24/2017)... ... January 24, 2017 , ... To answer the growing demand ... Companies, has designated The Deco a 55 and over residence. ... older in no less than 80% of occupied units. The Deco’s 114 apartments are ...
Breaking Medicine News(10 mins):